Radiation Oncology/Therapy: Page 16

ACS: COVID-19 increased deaths from cancer as contributing factor

By Kate Madden Yee

A new American Cancer Society (ACS) report has found that mortality rates with cancer as a contributing factor were higher in 2020 -- the first year of the COVID-19 pandemic -- compared with prepandemic 2019 rates.

April 10, 2023

Perimeter secures contract with healthcare marketing agency QooQoo

By AuntMinnie.com staff writers

Perimeter Medical Imaging AI has inked an agreement with healthcare marketing agency QooQoo to market Perimeter's S-Series optical coherence tomography device.

April 9, 2023

AI denoising reduces LDCT lung cancer screening exam radiation dose

By Kate Madden Yee

Researchers have found that an artificial intelligence (AI) denoising method can further reduce radiation dose needed for ultralow-dose CT (LDCT) lung cancer screening exams, according to a study published April 4 in Academic Radiology.

April 6, 2023

PET/CT reveals vascular effects of chemotherapy in lymphoma patients

By Will Morton

PET/CT imaging has shown for the first time in a clinical trial that aortic inflammation is reduced in lymphoma patients after first-line chemotherapy, according to a study published March 31 in JACC: Advances.

April 6, 2023

MRI-targeted biopsy finds clinically significant prostate cancers

By Kate Madden Yee

MRI-targeted biopsy prompted by elevated prostate-specific antigen (PSA) levels identifies fewer clinically insignificant prostate cancers than systemic biopsy, according to a paper published April 4 in the Annals of Internal Medicine.

April 5, 2023

Orbit, Evergreen to collaborate on new radiopharmaceuticals

By AuntMinnie.com staff writers

Orbit Discovery and Evergreen Discovery plan to collaborate on identifying cell-targeting peptides in order to develop new radiopharmaceuticals.

April 2, 2023

Ablaze secures peptide drug license from RayzeBio

By AuntMinnie.com staff writers

Ablaze Pharmaceuticals has licensed a peptide drug candidate from RayzeBio that it will develop to target the liver cancer biomarker GPC3. Ablaze plans to market the new drug in China, where the company is headquartered.

March 30, 2023

Accuray highlights prostate cancer treatment trial results

By AuntMinnie.com staff writers

Accuray is highlighting clinical results that show that, compared to surgery, stereotactic body radiation therapy better preserves urinary continence and sexual function in men with localized prostate cancer.

March 26, 2023

Telix gets FDA nod for gallium injection prep kit

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared Telix Pharmaceuticals' gallium-68 (Ga-68) gozetotide injection (Illuccix) preparation kit.

March 15, 2023

Curium confirms no supply challenges for Eclipse trial

By AuntMinnie.com staff writers

Nuclear medicine company Curium confirmed in a recent statement that it doesn't expect supply challenges of its lutetium-177 prostate-specific membrane antigen with 3-iodo-D-tyrosine for the company's Eclipse phase III clinical trial.

March 15, 2023

European companies to develop strategies for dismantling old cyclotrons

By AuntMinnie.com staff writers

A group of European companies plans to develop "turnkey" options for dismantling aging cyclotrons, according to an article in the Brussels Times.

March 9, 2023

Will lecanemab approval increase PET scan volumes?

By Will Morton

The European nuclear medicine community could see increased demand for PET imaging if the monoclonal antibody lecanemab receives approval for the treatment of Alzheimer's disease, according to the European Association for Nuclear Medicine.

March 8, 2023

Previous Page

Page 16 of 466

Next Page